Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

Becker's reported on 10 hospitals and practices adding spine and orthopedic robots since the beginning of September.

Here are five FDA alerts and recalls from 2024 for orthopedic and spine specialists to know: ...

A new medical technology fund which focusses on early-stage health technologies is itself an innovation. Utilizing its ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

Wise covers the Healthcare sector, focusing on stocks such as Medtronic, Zimmer Biomet Holdings ... Clinical Nutrition, Advanced Surgery and Acute Therapies. Read More on BAX: Baxter International ...

Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, is proud to announce the appointment ...

The global ageing population and growing awareness of the benefits of orthobiologic therapy are driving the size of the global orthobiologics market.